Nemaura Medical EBITDA 2014-2023 | NMRD

Nemaura Medical ebitda from 2014 to 2023. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$210.3B
Intuitive Surgical (ISRG)$183B
Alcon (ALC)$46B
Edwards Lifesciences (EW)$41.3B
IQVIA Holdings (IQV)$39.4B
IDEXX Laboratories (IDXX)$37.1B
DexCom (DXCM)$28B
STERIS (STE)$22.1B
SONOVA HOLDING (SONVY)$22.1B
Waters (WAT)$19.4B
Hologic (HOLX)$18.8B
Sysmex ADR (SSMXY)$11.6B
Fresenius Medical Care AG KGaA (FMS)$11.2B
Teleflex (TFX)$11.1B
Globus Medical (GMED)$10.2B
Penumbra (PEN)$8.2B
Glaukos (GKOS)$7.6B
Masimo (MASI)$7.6B
PROCEPT BioRobotics (PRCT)$4.9B
Integer Holdings (ITGR)$4.4B
LivaNova (LIVN)$2.8B
Inari Medical (NARI)$2.8B
TransMedics (TMDX)$2.7B
Veracyte (VCYT)$2.7B
Nihon Kohden (NHNKY)$2.6B
Elekta AB (EKTAY)$2.3B
Tandem Diabetes Care (TNDM)$2.1B
RxSight (RXST)$1.9B
Integra LifeSciences Holdings (IART)$1.5B
Artivion (AORT)$1.1B
Stock Screener
Stock Research
Top Dividend Stocks
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy

Nemaura Medical EBITDA 2014-2023 | NMRD

Nemaura Medical ebitda from 2014 to 2023. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket Cap
Thermo Fisher Scientific (TMO)$210.3B
Intuitive Surgical (ISRG)$183B
Alcon (ALC)$46B
Edwards Lifesciences (EW)$41.3B
IQVIA Holdings (IQV)$39.4B
IDEXX Laboratories (IDXX)$37.1B
DexCom (DXCM)$28B
STERIS (STE)$22.1B
SONOVA HOLDING (SONVY)$22.1B
Waters (WAT)$19.4B
Hologic (HOLX)$18.8B
Sysmex ADR (SSMXY)$11.6B
Fresenius Medical Care AG KGaA (FMS)$11.2B
Teleflex (TFX)$11.1B
Globus Medical (GMED)$10.2B
Penumbra (PEN)$8.2B
Glaukos (GKOS)$7.6B
Masimo (MASI)$7.6B
PROCEPT BioRobotics (PRCT)$4.9B
Integer Holdings (ITGR)$4.4B
LivaNova (LIVN)$2.8B
Inari Medical (NARI)$2.8B
TransMedics (TMDX)$2.7B
Veracyte (VCYT)$2.7B
Nihon Kohden (NHNKY)$2.6B
Elekta AB (EKTAY)$2.3B
Tandem Diabetes Care (TNDM)$2.1B
RxSight (RXST)$1.9B
Integra LifeSciences Holdings (IART)$1.5B
Artivion (AORT)$1.1B